RMD: Hold + Reduce with a $166.26 price target

Quarterly sales are growing, but the profit margin narrowed.

Target for 2027-09-14: $166.26 USD, -23.8% versus the $218.27 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.

Over 1 year (2025-09-12 to 2026-09-11), price changed -19.2% and trailing EPS changed +17.0%. A wider gap changes the earnings multiple; it does not establish fair value.

Revenue changed +8.6% from the same quarter last year, through 2026-06-30. The previous quarter’s year-on-year change was +10.8%.

Net debt / EBITDA: -0.3× for RMD, against 1.6× across 11 comparable peers.

The latest quarterly operating margin was 30.7%, -3.1 percentage points from a year earlier. The full report separates sales growth from margin changes.

The estimate for the period ending 2027-06-30 changed -0.1% over 30 days. Coverage is 20 analysts.

Compare the next results with the trailing margin of 33.4% and the annual-history median of 28.2%. A historical median is context, not a forecast.

The latest quarterly margin changed -3.1 percentage points from a year earlier. Check sales volumes, pricing and unusual gains in the next filing.

Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.

Starting annual sales growth: 9.94%.

Long-term operating margin: 30.46%.

Review recorded on 2026-09-17. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.